1. Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. Issue 10 (1st April 2022) Authors: Pires da Silva, Inês; Ahmed, Tasnia; McQuade, Jennifer L.; Nebhan, Caroline A.; Park, John J.; Versluis, Judith M.; Serra-Bellver, Patricio; Khan, Yasir; Slattery, Tim; Oberoi, Honey K.; Ugurel, Selma; Haydu, Lauren E.; Herbst, Rudolf; Utikal, Jochen; Pföhler, Claudia; Terheyden, Patrick; Weichen... Journal: Journal of clinical oncology Issue: Volume 40:Issue 10(2022) Page Start: 1068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma. (March 2023) Authors: Wong, Selina K.; Blum, Steven M.; Sun, Xiaopeng; Da Silva, Inês P.; Zubiri, Leyre; Ye, Fei; Bai, Kun; Zhang, Kevin; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Serra-Bellver, Patricio; Muñoz-Couselo, Eva; Ortiz, Carolina; Lostes, Julia; Huertas, Roberto M.; Arance, Ana... Journal: European journal of cancer Issue: Volume 181(2023) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study. Issue 6 (June 2021) Authors: Pires da Silva, Ines; Ahmed, Tasnia; Reijers, Irene L M; Weppler, Alison M; Betof Warner, Allison; Patrinely, James Randall; Serra-Bellver, Patricio; Allayous, Clara; Mangana, Joanna; Nguyen, Khang; Zimmer, Lisa; Trojaniello, Claudia; Stout, Dan; Lyle, Megan; Klein, Oliver; Gerard, Camille L; Mic... Journal: Lancet oncology Issue: Volume 22:Issue 6(2021) Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma – Authors' reply. Issue 8 (August 2021) Authors: da Silva, Ines Pires; Ahmed, Tasnia; Reijers, Irene L M; Warner, Allison Betof; Patrinely, James Randall; Serra-Bellver, Patricio; Allayous, Clara; Mangana, Joanna; Zimmer, Lisa; Trojaniello, Claudia; Klein, Oliver; Gerard, Camille L; Michielin, Olivier; Haydon, Andrew; Ascierto, Paolo A; Carlino... Journal: Lancet oncology Issue: Volume 22:Issue 8(2021) Page Start: e343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient and treatment characteristics of emergency presentations due to immune-mediated toxicities. (March 2022) Authors: Nahm, Sharon H.; Heywood, Richard; Callaghan, Sophia; Serra-Bellver, Patricio; Gupta, Avinash; Cooksley, Tim; Lorigan, Paul Journal: European journal of cancer Issue: Volume 164(2022) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sequential immunotherapy regimens—expect the unexpected. Issue 7 (July 2016) Authors: Serra-Bellver, Patricio; Valpione, Sara; Lorigan, Paul Journal: Lancet oncology Issue: Volume 17:Issue 7(2016:Jul.) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The role of nivolumab in melanoma. (June 2018) Authors: Gomes, Fabio; Serra-Bellver, Patricio; Lorigan, Paul Journal: Future oncology Issue: Volume 14:Number 13(2018) Page Start: 1241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tumour infiltrating B cells discriminate checkpoint blockade-induced responses. (December 2022) Authors: Valpione, Sara; Campana, Luca G.; Weightman, John; Salih, Zena; Galvani, Elena; Mundra, Piyushkumar A.; De Rosa, Francesco; Gupta, Avinash; Serra-Bellver, Patricio; Lorigan, Paul; Germetaki, Theodora; Dynowski, Marek; Kitcatt, Stephen; Sahoo, Sudhakar; Lee, Dave; Dhomen, Nathalie; Lord, Graham; M... Journal: European journal of cancer Issue: Volume 177(2022) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗